Saturday 17 October 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
11.68
0.70
−5.65%
Follow AMWL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 5 |
| (36.74%) | (33.93%) | (32.20%) | (29.54%) | ||
| (26.93%) | (25.19%) | (23.58%) | (21.82%) | ||
ROIC |
(115.53%) | (100.51%) | (95.94%) | (135.53%) | |
Return on Tangible Assets |
(61.34%) | (55.10%) | (50.09%) | (45.00%) | |
Average Days of Receivables |
76.54 | 72.75 | 87.79 | 87.87 | |
Free Cash Flow per Share |
(3.98) | (4.11) | (2.69) | (1.91) | |
Free Cash Flow |
(64.46) | (65.97) | (44.63) | (32.04) | |
Capital Expenditures |
(2.42) | (0.02) | (2.80) | (5.65) | |
| Other line items | |||||
Cash ROIC |
(13.77%) | (15.34%) | (10.62%) | (7.43%) | |
Accounts Receivable Turnover |
3.66 | 4.10 | 3.68 | 4.12 | |
Accounts Payable Turnover |
17.87 | 34.95 | 28.59 | 38.77 | |
Inventory Turnover |
38.31 | 57.59 | 60.80 | 66.81 | |
Average Days of Payables |
17.26 | 5.17 | 4.53 | 5.89 | |
Days of Inventory on Hand |
5.28 | 3.72 | 3.75 | 3.35 | |
Tax Rate |
0.02 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
29.32% | 29.22% | 26.60% | 25.28% | |
Selling, General and Administrative Expense of Revenue |
56.76% | 52.67% | 50.97% | 48.99% | |
Share Based Compensation of Revenue |
10.68% | 8.83% | 7.15% | 5.95% | |
Operating CF/Net income |
0.55 | 0.69 | 0.48 | 0.34 | |
Depreciation/Fixed assets |
149.41 | 167.12 | 209.24 | 217.48 | |
Capex/Depreciation |
(0.07) | 0.00 | (0.08) | (0.16) | |
Revenue per Share |
16.35 | 15.54 | 14.31 | 13.04 | |
Operating CF per Share |
(3.83) | (4.11) | (2.52) | (1.57) | |
Capex per Share |
(0.15) | 0.00 | (0.17) | (0.34) | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.03 |
Columns are period end dates